Rocket Pharmaceuticals Inc (RCKT)
22.79
+0.27
(+1.20%)
USD |
NASDAQ |
May 02, 16:00
22.79
0.00 (0.00%)
After-Hours: 19:25
Rocket Pharmaceuticals Cash from Financing (Quarterly): 0.391M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.391M |
| September 30, 2023 | 189.48M |
| June 30, 2023 | 0.182M |
| March 31, 2023 | 18.34M |
| December 31, 2022 | 108.44M |
| September 30, 2022 | 29.53M |
| June 30, 2022 | 17.25M |
| March 31, 2022 | 0.076M |
| December 31, 2021 | 1.136M |
| September 30, 2021 | 26.64M |
| June 30, 2021 | 1.115M |
| March 31, 2021 | 8.792M |
| December 31, 2020 | 282.44M |
| September 30, 2020 | 0.512M |
| June 30, 2020 | 0.151M |
| March 31, 2020 | -0.117M |
| December 31, 2019 | 92.41M |
| September 30, 2019 | 0.031M |
| June 30, 2019 | 85.35M |
| March 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2018 | 74.84M |
| September 30, 2018 | 0.149M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 78.52M |
| December 31, 2017 | -25.39M |
| September 30, 2017 | -0.039M |
| June 30, 2017 | 3.896M |
| March 31, 2017 | 21.55M |
| December 31, 2016 | 0.213M |
| September 30, 2016 | 48.69M |
| June 30, 2016 | 4.182M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.073M |
| September 30, 2015 | 73.97M |
| June 30, 2015 | -0.04M |
| March 31, 2015 | 51.51M |
| December 31, 2014 | 1.255M |
| September 30, 2014 | -0.687M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.117M
Minimum
Mar 2020
282.44M
Maximum
Dec 2020
45.38M
Average
8.792M
Median
Mar 2021
Cash from Financing (Quarterly) Benchmarks
| ADMA Biologics Inc | -38.99M |
| Geron Corp | 33.28M |
| Madrigal Pharmaceuticals Inc | 479.92M |
| Ligand Pharmaceuticals Inc | 5.315M |
| Puma Biotechnology Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -29.34M |
| Cash from Investing (Quarterly) | -140.80M |
| Free Cash Flow | -211.39M |
| Free Cash Flow Per Share (Quarterly) | -0.3637 |
| Free Cash Flow Yield | -11.04% |